Literature DB >> 7681861

Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.

A Sartorio1, A Spada, A Conti, G Grugni, F Morabito, G Faglia.   

Abstract

In order to understand the role exerted by the endogenous somatostatinergic tone in the blunting of GH responsiveness to repeated GHRH administration, we evaluated GH responses to the second GHRH bolus during a simultaneous infusion of galanin, which has been reported to inhibit the endogenous somatostatin release. Seven normal adults (3M/4F, age range 19-28 yr), admitted to the study after giving informed consent, were tested on three occasions, with a) two consecutive 1 micrograms/kg iv GHRH boluses administered at 0 min and 120 min, b) one GHRH bolus at 0 min followed by an infusion of 10 micrograms/kg bw galanin (diluted in 40 ml 0.9% NaCl) between 100 min and 140 min and c) two consecutive GHRH boluses (same dose and temporization of administration of test a) associated with a galanin infusion from 100 min to 140 min. GH responses were evaluated as the net incremental area under the curve (GH nAUC/h); all data were expressed as mean +/- SE. GH responses to the first GHRH bolus were similar in the three tests (mean GH nAUC, test A 990 +/- 80, test B: 1006 +/- 112, test C: 1077 +/- 80 ng/ml/h). In test A the second GHRH bolus was unable to sustain GH elevated levels (mean GH nAUC: 32 +/- 12 ng/ml/h vs first GHRH: 990 +/- 80 ng/ml/h, p < 0.0001). Similarly, in test B galanin infusion alone was unable to determine a clear GH rise (mean GH nAUC: -25 +/- 16 vs first GHRH: 1006 +/- 112 ng/ml/h, p < 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681861     DOI: 10.1007/BF03347656

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.

Authors:  J A Hulse; S M Rosenthal; L Cuttler; S L Kaplan; M M Grumbach
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

2.  Growth hormone release in man induced by galanin, a new hypothalamic peptide.

Authors:  F E Bauer; L Ginsberg; M Venetikou; D J MacKay; J M Burrin; S R Bloom
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

3.  Galanin: evidence for a hypothalamic site of action to release growth hormone.

Authors:  A Ottlecz; W K Samson; S M McCann
Journal:  Peptides       Date:  1986 Jan-Feb       Impact factor: 3.750

4.  Influence of coexisting hypothalamic messengers on growth hormone secretion from rat anterior pituitary cells in vitro.

Authors:  B Meister; A L Hulting
Journal:  Neuroendocrinology       Date:  1987-11       Impact factor: 4.914

5.  Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children.

Authors:  E Ghigo; S Goffi; E Mazza; E Arvat; M Procopio; J Bellone; E E Müller; F Camanni
Journal:  Acta Endocrinol (Copenh)       Date:  1989-05

6.  Chronic exposure of cultured rat anterior pituitary cells to GRF causes partial loss of responsiveness to GRF.

Authors:  L M Bilezikjian; W W Vale
Journal:  Endocrinology       Date:  1984-11       Impact factor: 4.736

7.  Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man.

Authors:  F Massara; E Ghigo; P Molinatti; E Mazza; V Locatelli; E E Müller; F Camanni
Journal:  Acta Endocrinol (Copenh)       Date:  1986-09

8.  Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.

Authors:  S Loche; N Vista; E Ghigo; S Vannelli; E Arvat; L Benso; R Corda; S G Cella; E E Müller; C Pintor
Journal:  Pediatr Res       Date:  1990-04       Impact factor: 3.756

9.  Nicotine from cigarette smoking enhances clonidine-induced increase of serum growth hormone concentrations in men.

Authors:  V Coiro; L d'Amato; E Borciani; G Rossi; L Camellini; M L Maffei; D Pignatti; P Chiodera
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

10.  Plasma GH responses to GHRH and insulin-induced hypoglycemia in man.

Authors:  T Shibasaki; M Hotta; A Masuda; T Imaki; N Obara; H Demura; N Ling; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

View more
  3 in total

1.  GH responsiveness to repeated GHRH or hexarelin administration in normal adults.

Authors:  A Sartorio; A Conti; S Ferrero; A Spada; G Faglia
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

2.  Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.

Authors:  A Sartorio; A Conti; M Monzani; G Faglia
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

3.  GH responses to two consecutive bouts of respiratory muscle endurance training in healthy adults.

Authors:  A Sartorio; F Agosti; A Patrizi; G Tringali; N Marazzi; M Giunta; E E Muller; A E Rigamonti
Journal:  J Endocrinol Invest       Date:  2012-07-24       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.